Bioventix PLC banner

Bioventix PLC
F:51B

Watchlist Manager
Bioventix PLC Logo
Bioventix PLC
F:51B
Watchlist
Price: 17.6 EUR Market Closed
Market Cap: €91.9m

Wall St Price Targets

51B Price Targets Summary
Bioventix PLC

Wall Street analysts forecast 51B stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for 51B is 68.7 EUR with a low forecast of 68.02 EUR and a high forecast of 70.72 EUR.

Lowest Forecast
Price Target
68.02 EUR
286% Upside
Average Forecast
Price Target
68.7 EUR
290% Upside
Highest Forecast
Price Target
70.72 EUR
302% Upside
Bioventix PLC Competitors:
Price Targets
EBMT
Eagle Bancorp Montana Inc
5% Upside
LAND
Gladstone Land Corp
32% Upside
IDXX
IDEXX Laboratories Inc
27% Upside
QXO
SilverSun Technologies Inc
109% Upside

Revenue
Forecast

14% / Year
Past Growth
-4% / Year
Estimated Growth
Estimates Accuracy
2%
Average Beat
14% / Year
Past Growth
-4% / Year
Estimated Growth
Estimates Accuracy
2%
Average Beat

Over the last 13 years, the compound annual growth rate for Revenue has been 14%. The projected CAGR for the next 1 year is -4%.

Gross Profit
Forecast

14% / Year
Past Growth
-3% / Year
Estimated Growth
Estimates Accuracy
0%
Average Beat
14% / Year
Past Growth
-3% / Year
Estimated Growth
Estimates Accuracy
0%
Average Beat

Over the last 13 years, the compound annual growth rate for Gross Profit has been 14%. The projected CAGR for the next 1 year is -3%.

Operating Income
Forecast

16% / Year
Past Growth
-6% / Year
Estimated Growth
Estimates Accuracy
0%
Average Beat
16% / Year
Past Growth
-6% / Year
Estimated Growth
Estimates Accuracy
0%
Average Beat

Over the last 13 years, the compound annual growth rate for Operating Income has been 16%. The projected CAGR for the next 1 year is -6%.

Pre-Tax Income
Forecast

16% / Year
Past Growth
-4% / Year
Estimated Growth
Estimates Accuracy
-2%
Average Miss
16% / Year
Past Growth
-4% / Year
Estimated Growth
Estimates Accuracy
-2%
Average Miss

Over the last 13 years, the compound annual growth rate for Pre-Tax Income has been 16%. The projected CAGR for the next 1 year is -4%.

Net Income
Forecast

15% / Year
Past Growth
-5% / Year
Estimated Growth
Estimates Accuracy
6%
Average Beat
15% / Year
Past Growth
-5% / Year
Estimated Growth
Estimates Accuracy
6%
Average Beat

Over the last 13 years, the compound annual growth rate for Net Income has been 15%. The projected CAGR for the next 1 year is -5%.

Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.

What is 51B's stock price target?
Price Target
68.7 EUR

According to Wall Street analysts, the average 1-year price target for 51B is 68.7 EUR with a low forecast of 68.02 EUR and a high forecast of 70.72 EUR.

What is the Revenue forecast for Bioventix PLC?
Projected CAGR
-4%

Over the last 13 years, the compound annual growth rate for Revenue has been 14%. The projected CAGR for the next 1 year is -4%.

What is the Gross Profit forecast for Bioventix PLC?
Projected CAGR
-3%

Over the last 13 years, the compound annual growth rate for Gross Profit has been 14%. The projected CAGR for the next 1 year is -3%.

What is the Operating Income forecast for Bioventix PLC?
Projected CAGR
-6%

Over the last 13 years, the compound annual growth rate for Operating Income has been 16%. The projected CAGR for the next 1 year is -6%.

What is the Pre-Tax Income forecast for Bioventix PLC?
Projected CAGR
-4%

Over the last 13 years, the compound annual growth rate for Pre-Tax Income has been 16%. The projected CAGR for the next 1 year is -4%.

What is the Net Income forecast for Bioventix PLC?
Projected CAGR
-5%

Over the last 13 years, the compound annual growth rate for Net Income has been 15%. The projected CAGR for the next 1 year is -5%.

Back to Top
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett